
Limerston-backed Prism acquires Repose
Limerston Capital has supported its portfolio company Prism Healthcare in the acquisition of Repose Furniture.
Since Limerston Capital invested in Prism Healthcare in December 2018, the group has acquired patient lifting and bathing supplier Assured Healthcare, moving and handling manufacturer Care-ability and pressure area care company Harvest. The acquisition of Repose is expected to extend Harvest's range of products sold into both long-term care and local authority equipment loan stores.
The GP bought Prism via its debut fund, Limerston Capital Partners I, which held a final close in August 2017 on £220m, exceeding its £200m target. The vehicle invests in UK lower-mid-market companies with EBITDA of £5-15m and potential for operational improvements.
The sale is the end of a four-year holding period for LDC, which acquired Prism from Toronto-based Prism Medical in a £30m deal. The transaction also included additional funding alongside the initial investment to support the company's buy-and-build strategy. HSBC provided a senior debt package and growth capex facilities to support the acquisition.
Company
Based in Cradley Heath, Repose designs, manufactures and distributes rise and recliner chairs for the healthcare sector in the UK and internationally. The company generates revenue of £7m and EBITDA of £1.7m.
People
Limerston Capital – Martim Avillez, Joao Rosa (founding partners).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater